Safe Orthopaedics S.A. | Mid-cap | Healthcare
€2.40
0.00%
| Safe Orthopaedics Stock Comparison:
Safe Orthopaedics vs EssilorLuxotticaSafe Orthopaedics vs Sartorius StedimSafe Orthopaedics vs Amplitude SurgicalSafe Orthopaedics vs Crossject S.ASafe Orthopaedics vs Visiomed Group SASafe Orthopaedics vs CAC 40 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 16.5M
Total Liabilities 17.8M
Shareholders Equity -1.3M

Cash Flow Metrics

Revenue & Profitability Trend

Safe Orthopaedics Income Statement From 2019 to 2023

Metric20232022202120202019
Revenue i5.8M5.9M4.6M3.7M4.8M
Cost of Goods Sold i1.5M1.9M2.0M2.3M3.4M
Gross Profit i4.3M3.9M2.6M1.4M1.4M
Gross Margin % i74.4%67.0%56.6%38.7%28.6%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i262.0K307.0K66.0K38.0K275.0K
Other Operating Expenses i1.6M2.1M2.4M2.0M3.4M
Total Operating Expenses i1.9M2.4M2.5M2.1M3.7M
Operating Income i-6.1M-6.0M-7.6M-6.7M-7.4M
Operating Margin % i-105.6%-102.2%-166.2%-181.0%-155.4%
Non-Operating Items
Interest Income i----475.0K
Interest Expense i218.0K424.0K638.0K861.0K1.2M
Other Non-Operating Income-----
Pre-tax Income i-271.3M-7.0M-6.7M-8.3M-8.0M
Income Tax i-65.9M-1.0K000
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-205.4M-7.0M-6.7M-8.3M-8.0M
Net Margin % i-3,536.0%-118.8%-147.1%-225.5%-166.3%
Key Metrics
EBITDA i-266.7M-5.6M-5.2M-6.9M-6.4M
EPS (Basic) i-€-90.00€-1,341,800.00€-2,768,666.67€-7,289.00
EPS (Diluted) i-€-90.00€-31,190,999.69€-38,627,999.61€-21,866,999.78
Basic Shares Outstanding i-72435531094
Diluted Shares Outstanding i-72435531094

Income Statement Trend

Safe Orthopaedics Balance Sheet From 2019 to 2023

Metric20232022202120202019
Assets
Current Assets
Cash & Equivalents i780.0K302.0K913.0K2.4M125.0K
Short-term Investments i-----
Accounts Receivable i2.1M2.4M1.3M1.4M780.0K
Inventory i4.3M4.5M3.6M2.9M2.1M
Other Current Assets90.0K161.0K-1.0K2.0K-
Total Current Assets i8.5M9.3M8.2M8.4M3.6M
Non-Current Assets
Property, Plant & Equipment i3.6M5.3M7.7M6.5M3.4M
Goodwill i10.0K3.8M4.0M4.1M461.0K
Intangible Assets i10.0K187.0K23.0K39.0K3.0K
Long-term Investments-----
Other Non-Current Assets--96.0K-1.0K-1.0K1.0K
Total Non-Current Assets i69.5M7.3M6.6M5.9M2.0M
Total Assets i77.9M16.5M14.9M14.3M5.6M
Liabilities
Current Liabilities
Accounts Payable i2.1M3.6M1.9M1.8M2.1M
Short-term Debt i268.4M5.0M3.6M935.0K845.0K
Current Portion of Long-term Debt-----
Other Current Liabilities2.4M1.8M333.0K318.0K295.0K
Total Current Liabilities i275.2M12.4M9.0M5.8M4.1M
Non-Current Liabilities
Long-term Debt i2.8M5.1M5.3M8.2M5.8M
Deferred Tax Liabilities i39.0K148.0K--0
Other Non-Current Liabilities2.2M10.0K57.0K1.0K-
Total Non-Current Liabilities i5.0M5.3M5.4M8.3M5.8M
Total Liabilities i280.3M17.8M14.5M14.1M9.9M
Equity
Common Stock i3.4M14.2M5.6M3.4M1.9M
Retained Earnings i-205.4M-7.0M-6.7M-8.3M-8.0M
Treasury Stock i-78.0K79.0K80.0K79.0K
Other Equity-----
Total Shareholders Equity i-202.4M-1.3M398.0K237.0K-4.3M
Key Metrics
Total Debt i271.2M10.1M8.9M9.1M6.6M
Working Capital i-266.8M-3.2M-799.0K2.6M-488.0K

Balance Sheet Composition

Safe Orthopaedics Cash Flow Statement From 2019 to 2023

Metric20232022202120202019
Operating Activities
Net Income i-205.4M-7.0M-6.7M-8.3M-8.0M
Depreciation & Amortization i-----
Stock-Based Compensation i39.0K---8.0K
Working Capital Changes i2.2M182.0K0945.0K2.5M
Operating Cash Flow i-5.5M-6.4M-5.6M-6.6M-4.3M
Investing Activities
Capital Expenditures i-56.0K-858.0K-2.0M-548.0K-451.0K
Acquisitions i-----
Investment Purchases i-----
Investment Sales i-262.0K36.0K6.0K-
Investing Cash Flow i-56.0K-597.0K-2.7M-3.0M-452.0K
Financing Activities
Share Repurchases i-----102.0K
Dividends Paid i-----
Debt Issuance i00658.0K1.4M379.0K
Debt Repayment i-2.3M-3.1M-430.0K-748.0K-373.0K
Financing Cash Flow i1.7M5.7M8.1M11.9M2.5M
Free Cash Flow i-1.2M-6.3M-8.2M-6.5M-4.3M
Net Change in Cash i-3.8M-1.3M-256.0K2.3M-2.3M

Cash Flow Trend

Safe Orthopaedics Key Financial Ratios

Valuation Ratios

Forward P/E -34.29
Price to Sales 0.04
PEG Ratio -34.29

Profitability Ratios

Profit Margin 74.41%
Operating Margin -263.51%
Return on Equity 101.53%
Return on Assets -8.19%

Financial Health

Current Ratio 0.03
Debt to Equity -156.53
Beta 0.31

Per Share Data

EPS (TTM) €-18,676,728.00
Book Value per Share €-211.62
Revenue per Share €76.55

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
alsaf218.9M--101.53%74.41%-156.53
EssilorLuxottica 125.7B51.653.256.44%8.74%36.58
Sartorius Stedim 17.5B75.264.315.69%7.78%73.51
Amplitude Surgical 299.8M312.503.171.15%1.00%126.32
Crossject S.A 81.9M--478.68%0.00%-7.88
Visiomed Group SA 66.3M75.17-3.64%45.95%0.32

Financial data is updated regularly. All figures are in the company's reporting currency.